Mutations in ELAC2 associated with hypertrophic cardiomyopathy impair mitochondrial tRNA 3’-end processing
Authors:
- Makenzie SaouraMSMakenzie Saoura
- Christopher A. PowellCPChristopher A. Powell
- Robert KopajtichRKRobert Kopajtich
- Ahmad AlahmadAAAhmad Alahmad
- Haya H. Al-BaloolHAHaya H. Al-Balool
- Buthaina AlbashBAButhaina Albash
- Majid AlfadhelMAMajid Alfadhel
- Charlotte L. AlstonCACharlotte L. Alston
- Enrico BertiniEBEnrico Bertini
- Penelope BonnenPBPenelope Bonnen
- Drago BratkovicDBDrago Bratkovic
- Rosalba CarrozzoRCRosalba Carrozzo
Preprint
Abstract
Dysfunction of mitochondrial gene expression, caused by mutations in either the mitochondrial or nuclear genomes, is associated with a diverse group of human disorders characterized by impaired mitochondrial respiration. Within this group, an increasing number of mutations have been identified in nuclear genes involved in mitochondrial RNA metabolism. For instance, pathogenic mutations have been identified in the genes encoding enzymes involved in the precursor transcript processing, including ELAC2. The ELAC2 gene codes for the mitochondrial RNase Z, which is responsible for endonucleolytic cleavage of the 3’ ends of mitochondrial pre-tRNAs. Here, we report the identification of sixteen novel ELAC2 variants in individuals presenting with mitochondrial respiratory chain deficiency, hypertrophic cardiomyopathy and lactic acidosis. We provided further evidence for the pathogenicity of the three previously reported variants by studying the RNase Z activity in an in vitro system and applied this recombinant system to investigate all novel missense variants, confirming the pathogenic role of these new ELAC2 mutations. We also modelled the residues affected by missense mutation in solved RNase Z structures, providing insight into enzyme structure and function. Finally, we show that primary fibroblasts from the individuals with novel ELAC2 variants have elevated levels of unprocessed mitochondrial RNA precursors. Our study thus broadly confirms the correlation of ELAC2 variants with severe infantile-onset forms of hypertrophic cardiomyopathy and mitochondrial respiratory chain dysfunction. One rare missense variant associated with the occurrence of prostate cancer (p.Arg781His) impairs the mitochondrial RNase Z activity of ELAC2, possibly indicating a functional link between tumorigenesis and mitochondrial RNA metabolism.Keywords
All Related Versions
- Published version: Human Mutation, 40 (10), 1731.
This publication has 61 references indexed in Scilit:
- Mutations in FBXL4 Cause Mitochondrial Encephalopathy and a Disorder of Mitochondrial DNA MaintenanceThe American Journal of Human Genetics, 2013
- Identification and Sequence Analysis of Metazoan tRNA 3′-End Processing Enzymes tRNase ZsPLOS ONE, 2012
- Mutations of the Mitochondrial-tRNA Modifier MTO1 Cause Hypertrophic Cardiomyopathy and Lactic AcidosisThe American Journal of Human Genetics, 2012
- Pathogenesis-related mutations in the T-loops of human mitochondrial tRNAs affect 3′ end processing and tRNA structureRNA Biology, 2012
- Exome Sequencing Identifies Mitochondrial Alanyl-tRNA Synthetase Mutations in Infantile Mitochondrial CardiomyopathyThe American Journal of Human Genetics, 2011
- A method and server for predicting damaging missense mutationsNature Methods, 2010
- Acute Infantile Liver Failure Due to Mutations in the TRMU GeneThe American Journal of Human Genetics, 2009
- Prediction and assessment of splicing alterations: implications for clinical testingHuman Mutation, 2008
- RNase P without RNA: Identification and Functional Reconstitution of the Human Mitochondrial tRNA Processing EnzymeCell, 2008
- tRNase Z Catalysis and Conserved Residues on the Carboxy Side of the His ClusterBiochemistry, 2007